This study illustrated that in pancreatic ductal adenocarcinoma (PDAC), even after oncogene ablation of mutated KRAS and p53, the primary drivers of PDAC, a subset of quiescent tumor cells exhibiting characteristics of CSCs persists. Here, TP53 is linked to neoplasm.